phrykt

SBC Medical Group Holdings Inc (SBC): who owns it and who trades it

As of Nov 16, 2026, SBC insiders reported 3 open-market sales worth $20.1M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Yoshiyuki Aikawa (CEO), with $20.1M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling SBC Medical Group

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns SBC

57 funds and institutions reported SBC shares worth $13.7M at the end of Q2 2026, about 4% of the company. The largest holder is Lumbard & Kellner, LLC with 1.7%.

Funds and institutions (13F) 4%Everyone else 96%

10 largest owners, by share of the company

Lumbard & Kellner, LLC1.7%
BlackRock, Inc.0.9%
Geode Capital Management, LLC0.4%
Citadel Advisors LLC0.1%
Vanguard Capital Management LLC0.1%
Northern Trust Corp0.1%
Vanguard Portfolio Management LLC0.1%
Hillsdale Investment Management Inc.0.1%
Segall Bryant & Hamill, LLC0.1%
Vanguard Fiduciary Trust Co0.1%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Lumbard & Kellner, LLC1.73M1.68%$5.3M–
BlackRock, Inc.924,0020.90%$2.8M–
Geode Capital Management, LLC427,8640.42%$1.3M–
Citadel Advisors LLC144,7180.14%$446K–
Vanguard Capital Management LLC135,7830.13%$418K–
Northern Trust Corp131,2040.13%$404K–
Vanguard Portfolio Management LLC128,2950.13%$395K–
Hillsdale Investment Management Inc.124,8000.12%$384K–
Segall Bryant & Hamill, LLC81,3070.08%$250K–
Vanguard Fiduciary Trust Co66,2810.06%$204K–
SBI Securities Co., Ltd.49,4370.05%$152K–
State Street Corp49,2390.05%$152K–
Charles Schwab Investment Management Inc46,8550.05%$144K–
Sixth Street Partners Management Company, L.P.46,8550.05%$144K–
Mariner, LLC33,7470.03%$104K–
Bank of New York Mellon Corp26,9910.03%$83.1K–
Nuveen, LLC25,3810.02%$78.2K–
AQR Capital Management LLC24,0980.02%$74.2K–
Central Pacific Bank - Trust Division24,0000.02%$73.9K–
Two Sigma Securities, LLC21,4870.02%$66.2K–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, SBC insiders reported $0 of open-market purchases and $20.1M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$20.1M
3 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Apr 28, 2026
Filed Apr 29, 2026

Purchases and sales by month

$10.8M$10.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Apr 28, 2026Yoshiyuki AikawaCEOSale465,000$3.02$1.4MForm 4
Apr 21, 2026Yoshiyuki AikawaCEOSale3.10M$3.02$9.4MForm 4
Mar 6, 2026Yoshiyuki AikawaCEOSale4.42M$2.12$9.4MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Yoshiyuki AikawaChairman and CEO, Director, 10% owner–$20.1MApr 28, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SBC short interest

Low short interest. 0.8% of SBC shares are sold short: about 1 share in 122. Over the last 12 reports the number of shares short went up 207%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 840,714 SBC shares were sold short, 0.8% of the shares outstanding, up 12.0% from the report before. At the average daily volume of 184,147 shares, buying them all back would take about 4.6 trading days (days to cover).

Shares short, % of all shares

0.82%May 15Oct 300.99%

Days to cover

4.6May 15Oct 3013.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026840,7140.82%+12%184,1474.6
Oct 15, 2026750,8130.73%-8%192,2283.9
Sep 30, 2026813,9000.79%+13%241,8343.4
Sep 15, 2026717,5320.70%+3%176,8714.1
Aug 31, 2026696,1670.68%+3%203,1973.4
Aug 14, 2026674,5470.66%-17%144,9614.7
Jul 31, 2026814,0230.79%-11%67,09812.1
Jul 15, 2026914,8130.89%+67%93,7989.8
Jun 30, 2026549,1710.54%+45%203,8602.7
Jun 15, 2026377,5720.37%-3%103,7703.6
May 29, 2026388,6500.38%+42%137,4902.8
May 15, 2026273,4450.27%-12%129,4722.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

SBC Medical Group company events

SBC Medical Group filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Aug 13, 2026.

  1. Aug 13, 2026ResultsReleased financial results. Filing
  2. Jul 14, 2026ListingThe date of the 2026 Annual Meeting of Stockholders of SBC Medical Group Holdings Incorporated, the Company notified the Listing Qualifications Department of the Nasdaq Stock Market LLC, that as of the Annual Meeting, the Company would cease to be in compliance with the Nasdaq independence rules… Filing
  3. May 20, 2026LeadershipMike Sayama, an independent director of SBC Medical Group Holdings Incorporated, notified the Company that he would not seek re-election at the Company’s forthcoming 2026 Annual Meeting of Stockholders. Filing
  4. May 14, 2026ResultsReleased financial results. Filing
  5. Apr 23, 2026AgreementSBC Medical Group Holdings Incorporated entered into an underwriting agreement by and among the Company, Dr. Yoshiyuki Aikawa, the Company’s CEO and Chairman of the board of directors, as selling stockholder and Maxim Group LLC, as representative of the several underwriters named in Schedule 1… Filing
  6. Mar 27, 2026AnnouncementIn connection with the Company’s announcements described in this Current Report on Form 8-K, the Company announced certain updates to its business strategy and capital policy, as summarized in Exhibit 99.2 hereto, which is incorporated herein by reference. Filing
  7. Jan 5, 2026AnnouncementOf this Current Report on Form 8-K. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Filing
  8. Dec 31, 2025AnnouncementOf this Current Report on Form 8-K. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Filing
  9. Dec 15, 2025AnnouncementSBC Medical Group Holdings Incorporated issued a press release announcing that the final results of the tender offer conducted by SBC Medical Group Co., Ltd. for shares of the common stock of Waqoo, Inc., a Japanese corporation listed on the Tokyo Stock Exchange Growth Market. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

SBC Medical Group financials

Famous investors that hold SBC

2 of the 50 well-known investors we track reported holding SBC in their latest 13F filing. The largest position is Ken Griffin's, worth $300K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202660,723$300K0.0%-58%
Israel Englander · Millennium ManagementQ3 202613,436$66.4K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about SBC Medical Group Holdings Inc (SBC) stock

Who owns the most SBC stock?

The largest reported owner of SBC Medical Group Holdings Inc (SBC) is Lumbard & Kellner, LLC, with 1.7% of the company. In total, 57 funds and institutions reported holding SBC at the end of Q2 2026, together about 4% of the shares. See the largest owners.

Are SBC insiders buying or selling?

In the last 12 months, SBC insiders reported no open-market purchases and 3 sales worth $20.1M. The latest trade was on Apr 28, 2026. See every trade.

What is the short interest in SBC?

As of Oct 30, 2026, 840,714 SBC shares were sold short, 0.8% of the shares outstanding, up 12.0% from the report before. At the average daily volume of 184,147 shares, buying them all back would take about 4.6 trading days (days to cover). See the history.

Which famous investors hold SBC?

2 of the 50 well-known investors we track reported SBC in their latest 13F filing, including Ken Griffin, Israel Englander. The largest position is worth $300K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.